| |
| |
|
| Insider
Information: |
Mulroy Michael H. |
| Relationship: |
|
| City: |
Anaheim |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
602,177 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$497,853 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
602,177 |
|
|
| Total
Value |
$497,853 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Comarco Inc |
CMRO |
Director |
2013-10-08 |
70,000 |
2011-07-21 |
0 |
Premium* |
|
|
Questcor Pharmaceuticals Inc |
QCOR |
EVP, Strat. Affairs & GC |
2014-08-14 |
0 |
2012-05-23 |
0 |
Premium* |
|
|
Lineage Cell Therapeutics Ord Shs |
LCTX |
Director |
2022-03-24 |
258,555 |
|
0 |
Premium* |
|
|
Asterias Biotherapeutics Inc |
AST |
|
2019-03-01 |
273,622 |
2017-09-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • – |
2022-03-24 |
4 |
B |
$1.40 |
$9,800 |
D/D |
7,000 |
258,555 |
2.39 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • – |
2021-06-18 |
4 |
OE |
$2.20 |
$54,384 |
D/D |
24,720 |
251,555 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • – |
2019-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
194,271 |
226,821 |
0 |
- |
|
| AST |
Asterias Biotherapeutics ... |
President and CEO |
• • – |
2019-03-01 |
4 |
D |
$0.95 |
$72,759 |
D/D |
(76,588) |
273,622 |
0 |
- |
|
| AST |
Asterias Biotherapeutics ... |
President and CEO |
• • – |
2019-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
252,606 |
350,210 |
0 |
- |
|
| AST |
Asterias Biotherapeutics ... |
President and CEO |
• • – |
2018-08-27 |
4 |
AB |
$1.59 |
$5,000 |
D/D |
3,141 |
97,604 |
0 |
- |
|
| AST |
Asterias Biotherapeutics ... |
President and CEO |
• • – |
2018-07-25 |
4 |
AB |
$1.69 |
$5,000 |
D/D |
2,950 |
94,463 |
0 |
- |
|
| AST |
Asterias Biotherapeutics ... |
President and CEO |
• • – |
2018-06-25 |
4 |
AB |
$1.63 |
$4,999 |
D/D |
3,067 |
91,513 |
0 |
- |
|
| AST |
Asterias Biotherapeutics ... |
President and CEO |
• • – |
2018-05-25 |
4 |
AB |
$1.59 |
$5,000 |
D/D |
3,153 |
88,446 |
0 |
- |
|
| AST |
Asterias Biotherapeutics ... |
President and CEO |
• • – |
2018-04-25 |
4 |
AB |
$1.33 |
$4,990 |
D/D |
3,752 |
85,293 |
0 |
- |
|
| AST |
Asterias Biotherapeutics ... |
President and CEO |
• • – |
2018-03-26 |
4 |
AB |
$1.76 |
$4,997 |
D/D |
2,839 |
81,541 |
0 |
- |
|
| AST |
Asterias Biotherapeutics ... |
President and CEO |
• • – |
2018-03-15 |
4 |
D |
$1.95 |
$55,298 |
D/D |
(28,358) |
78,702 |
0 |
- |
|
| AST |
Asterias Biotherapeutics ... |
President and CEO |
• • – |
2018-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
94,872 |
107,060 |
0 |
- |
|
| AST |
Asterias Biotherapeutics ... |
President and CEO |
• • – |
2018-01-25 |
4 |
AB |
$2.34 |
$5,000 |
D/D |
2,134 |
9,933 |
0 |
- |
|
| AST |
Asterias Biotherapeutics ... |
President and CEO |
• • – |
2017-12-26 |
4 |
AB |
$2.22 |
$4,988 |
D/D |
2,247 |
7,799 |
0 |
- |
|
| AST |
Asterias Biotherapeutics ... |
President and CEO |
• • – |
2017-11-27 |
4 |
AB |
$2.41 |
$5,003 |
D/D |
2,076 |
5,552 |
0 |
- |
|
| AST |
Asterias Biotherapeutics ... |
President and CEO |
• • – |
2017-10-25 |
4 |
AB |
$2.55 |
$4,944 |
D/D |
1,939 |
3,476 |
0 |
- |
|
| AST |
Asterias Biotherapeutics ... |
President and CEO |
• • – |
2017-09-25 |
4 |
AB |
$3.25 |
$4,997 |
D/D |
1,537 |
1,537 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • – |
2014-10-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
32,550 |
|
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
EVP, Strat. Affairs & GC |
• – – |
2014-08-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(73,259) |
0 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
See Remarks |
• – – |
2014-08-11 |
4 |
AS |
$92.32 |
$923,348 |
D/D |
(10,000) |
65,714 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
See Remarks |
• – – |
2014-08-06 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,349 |
75,714 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
See Remarks |
• – – |
2014-07-31 |
4 |
D |
$92.35 |
$120,424 |
D/D |
(1,304) |
75,759 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
See Remarks |
• – – |
2014-07-10 |
4 |
S |
$90.86 |
$908,912 |
D/D |
(10,000) |
77,063 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
See Remarks |
• – – |
2014-07-10 |
4 |
OE |
$14.24 |
$142,400 |
D/D |
10,000 |
87,063 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
